{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:25:36Z","timestamp":1785403536066,"version":"3.56.0"},"reference-count":76,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interv Cardiol"],"abstract":"<jats:p>Transcatheter aortic valve (TAV) implantation is an established treatment strategy for patients with severe aortic stenosis across the spectrum of surgical risk profiles. Numerous randomised controlled trials have consistently demonstrated the safety and efficacy of TAV implantation compared with surgical aortic valve replacement, prompting an expansion of indications towards lower surgical risk, often younger, patients. In parallel, the number and types of TAV prosthesis have also increased. Although all devices have generally demonstrated favourable procedural and longer-term clinical outcomes, variations in frame design, material properties and leaflet configurations render specific devices more favourable in certain settings. In this review, we describe key differences in TAV design and how this may affect the choice of TAV prosthesis in the challenging clinical scenarios of patients with small annuli, coronary disease, long life expectancy, risk of permanent pacing and aortic regurgitation, which are expected to be encountered more frequently as indications for TAV implantation expand.<\/jats:p>","DOI":"10.15420\/icr.2024.40","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:48:52Z","timestamp":1765198132000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient-specific Factors Influencing Choice of Transcatheter Aortic Valve Prosthesis"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4455-2865","authenticated-orcid":false,"given":"Arif A","family":"Khokhar","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bpbnx46","id-type":"ROR","asserted-by":"publisher"}],"name":"Copenhagen University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Curio","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05mxhda18","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hammond-Haley","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05jg8yp15","id-type":"ROR","asserted-by":"publisher"}],"name":"Hammersmith Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Adam","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05mxhda18","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ruparelia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05jg8yp15","id-type":"ROR","asserted-by":"publisher"}],"name":"Hammersmith Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"ref0","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395; PMID:\u00a034453165."},{"key":"ref1","unstructured":"Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695\u2013705. https:\/\/doi.org\/10.1056\/NEJMoa1814052; PMID:\u00a030883058."},{"key":"ref2","unstructured":"Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med 2023;389:1949\u201360. https:\/\/doi.org\/10.1056\/NEJMoa2307447; PMID:\u00a037874020."},{"key":"ref3","unstructured":"Forrest JK, Deeb GM, Yakubov SJ, et al. 4-Year outcomes of patients with aortic stenosis in the Evolut low risk trial. J Am Coll Cardiol 2023;82:2163\u20135. https:\/\/doi.org\/10.1016\/j.jacc.2023.09.813; PMID:\u00a037877907."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Yerasi C, Rogers T, Forrestal BJ, et al. Transcatheter versus surgical aortic valve replacement in young, low-risk patients with severe aortic stenosis. JACC Cardiovasc Interv 2021;14:1169\u201380. https:\/\/doi.org\/10.1016\/j.jcin.2021.03.058; PMID:\u00a034112453.","DOI":"10.1016\/j.jcin.2021.03.058"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Windecker S, Okuno T, Unbehaun A, et al. Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation? Eur Heart J 2022;43:2729\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehac105; PMID:\u00a035466382.","DOI":"10.1093\/eurheartj\/ehac105"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Revaiah PC, Jose J, Gunasekaran S, et al. Neocommissural\/coronary alignment with a novel balloon expandable transcatheter aortic valve: first-in-human experience. JACC Cardiovasc Interv 2023;16:2581\u20133. https:\/\/doi.org\/10.1016\/j.jcin.2023.07.012; PMID:\u00a037737798.","DOI":"10.1016\/j.jcin.2023.07.012"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ielasi A, Caminiti R, Pellegrini D, et al. Technical aspects for transcatheter aortic valve replacement with the novel balloon-expandable Myval Octacor. JACC Cardiovasc Interv 2024;17:101\u20133. https:\/\/doi.org\/10.1016\/j.jcin.2023.11.011; PMID:\u00a038199746.","DOI":"10.1016\/j.jcin.2023.11.011"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Kodali SK, Sorajja P, Meduri CU, et al. Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve \u2013 DurAVR. EuroIntervention 2023;19:e352\u201362. https:\/\/doi.org\/10.4244\/EIJ-D-23-00282; PMID:\u00a037334801.","DOI":"10.4244\/EIJ-D-23-00282"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Meier D, Akodad M, Landes U, et al. Coronary access following redo TAVR: impact of THV design, implant technique, and cell misalignment. JACC Cardiovasc Interv 2022;15:1519\u201331. https:\/\/doi.org\/10.1016\/j.jcin.2022.05.005; PMID:\u00a035926919.","DOI":"10.1016\/j.jcin.2022.05.005"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Wang B, Mei Z, Ge X, et al. Comparison of outcomes of self-expanding versus balloon-expandable valves for transcatheter aortic valve replacement: a meta-analysis of randomized and propensity-matched studies. BMC Cardiovasc Disord 2023;23:382. https:\/\/doi.org\/10.1186\/s12872-023-03397-3; PMID:\u00a037525092.","DOI":"10.1186\/s12872-023-03397-3"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Pascual I, Hern\u00e1ndez-Vaquero D, Alperi A, et al. Permanent pacemaker reduction using cusp-overlapping projection in TAVR: a propensity score analysis. JACC Cardiovasc Interv 2022;15:150\u201361. https:\/\/doi.org\/10.1016\/j.jcin.2021.10.002; PMID:\u00a035057985.","DOI":"10.1016\/j.jcin.2021.10.002"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ali N, Hildick-Smith D, Parker J, et al. Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry. Catheter Cardiovasc Interv 2023;101:932\u201342. https:\/\/doi.org\/10.1002\/ccd.30627; PMID:\u00a036924015.","DOI":"10.1002\/ccd.30627"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Deeb GM, Chetcuti SJ, Yakubov SJ, et al. Impact of annular size on outcomes after surgical or transcatheter aortic valve replacement. Ann Thorac Surg 2018;105:1129\u201336. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.08.059; PMID:\u00a029307456.","DOI":"10.1016\/j.athoracsur.2017.08.059"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Rod\u00e9s-Cabau J, Abbas AE, Serra V, et al. Balloon- vs self-expanding valve systems for failed small surgical aortic valve bioprostheses. J Am Coll Cardiol 2022;80:681\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2022.05.005; PMID:\u00a035597385.","DOI":"10.1016\/j.jacc.2022.05.005"},{"key":"ref15","unstructured":"Herrmann HC, Mehran R, Blackman DJ, et al. Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus. N Engl J Med 2024;390:1959\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2312573; PMID:\u00a038587261."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Freitas-Ferraz AB, Tirado-Conte G, Dagenais F, et al. Aortic stenosis and small aortic annulus. Circulation 2019;139:2685\u2013702. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038408; PMID:\u00a031157994.","DOI":"10.1161\/CIRCULATIONAHA.118.038408"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Head SJ, Mokhles MM, Osnabrugge RLJ, et al. The impact of prosthesis\u2013patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27\u00a0186 patients with 133\u00a0141 patient-years. Eur Heart J 2012;33:1518\u201329. https:\/\/doi.org\/10.1093\/eurheartj\/ehs003; PMID:\u00a022408037.","DOI":"10.1093\/eurheartj\/ehs003"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Flameng W, Herregods MC, Vercalsteren M, et al. Prosthesis\u2013patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation 2010;121:2123\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.901272; PMID:\u00a020439787.","DOI":"10.1161\/CIRCULATIONAHA.109.901272"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Martin C, Sun W. Transcatheter valve underexpansion limits leaflet durability: implications for valve-in-valve procedures. Ann Biomed Eng 2017;45:394\u2013404. https:\/\/doi.org\/10.1007\/s10439-016-1738-8; PMID:\u00a027734178.","DOI":"10.1007\/s10439-016-1738-8"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC Cardiovasc Interv 2020;13:2542\u201355. https:\/\/doi.org\/10.1016\/j.jcin.2020.07.006; PMID:\u00a033069648.","DOI":"10.1016\/j.jcin.2020.07.006"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Abbas AE, Khalili H, Madanat L, et al. Echocardiographic versus invasive aortic valve gradients in different clinical scenarios. J Am Soc Echocardiogr 2023;36:1302\u201314. https:\/\/doi.org\/10.1016\/j.echo.2023.06.016; PMID:\u00a037507058.","DOI":"10.1016\/j.echo.2023.06.016"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"van den Dorpel MMP, Chatterjee S, Adrichem R, et al. Prognostic value of invasive versus echocardiography-derived aortic gradient in patients undergoing TAVI. EuroIntervention 2025;21:e411\u201325. https:\/\/doi.org\/10.4244\/EIJ-D-24-00341; PMID:\u00a040259836.","DOI":"10.4244\/EIJ-D-24-00341"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Nuche J, Abbas AE, Serra V, et al. Balloon- vs self-expanding transcatheter valves for failed small surgical aortic bioprostheses: 1-year results of the LYTEN trial. JACC Cardiovasc Interv 2023;16:2999\u20133012. https:\/\/doi.org\/10.1016\/j.jcin.2023.10.028; PMID:\u00a037902146.","DOI":"10.1016\/j.jcin.2023.10.028"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol 2018;71:1360\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.057; PMID:\u00a029566822.","DOI":"10.1016\/j.jacc.2018.01.057"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: the ALIGN-ACCESS study. Circ Cardiovasc Interv 2022;15:e011045. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.121.011045; PMID:\u00a035167332.","DOI":"10.1161\/CIRCINTERVENTIONS.121.011045"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Costa G, Sammartino S, Strazzieri O, et al. Coronary cannulation following TAVR using self-expanding devices with commissural alignment: the RE-ACCESS 2 study. JACC Cardiovasc Interv 2024;17:727\u201337. https:\/\/doi.org\/10.1016\/j.jcin.2023.12.015; PMID:\u00a038456879.","DOI":"10.1016\/j.jcin.2023.12.015"},{"key":"ref27","unstructured":"Costa G, Pilgrim T, Amat Santos IJ, et al. Management of myocardial revascularization in patients with stable coronary artery disease undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv 2022;15:e012417. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.122.012417; PMID:\u00a036538579."},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Patterson T, Clayton T, Dodd M, et al. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial. JACC Cardiovasc Interv 2021;14:1965\u201374. https:\/\/doi.org\/10.1016\/j.jcin.2021.06.041; PMID:\u00a034556269.","DOI":"10.1016\/j.jcin.2021.06.041"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Caminiti R, Ielasi A, Vetta G, et al. Percutaneous coronary intervention before or after transcatheter aortic valve replacement: a systematic review and meta-analysis involving 1531 patients. J Clin Med 2024;13:3521. https:\/\/doi.org\/10.3390\/jcm13123521; PMID:\u00a038930050.","DOI":"10.3390\/jcm13123521"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Stefanini GG, Cerrato E, Pivato CA, et al. Unplanned percutaneous coronary revascularization after TAVR: a multicenter international registry. JACC Cardiovasc Interv 2021;14:198\u2013207. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.031; PMID:\u00a033478637.","DOI":"10.1016\/j.jcin.2020.10.031"},{"key":"ref31","unstructured":"Kim WK, Pellegrini C, Ludwig S, et al. Feasibility of coronary access in patients with acute coronary syndrome and previous TAVR. JACC Cardiovasc Interv 2021;14:1578\u201390. https:\/\/doi.org\/10.1016\/j.jcin.2021.05.007; PMID:\u00a034294400."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Faroux L, Munoz-Garcia E, Serra V, et al. Acute coronary syndrome following transcatheter aortic valve replacement. Circ Cardiovasc Interv 2020;13:e008620. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.119.008620; PMID:\u00a031992059.","DOI":"10.1161\/CIRCINTERVENTIONS.119.008620"},{"key":"ref33","unstructured":"Faroux L, Lhermusier T, Vincent F, et al. ST-segment elevation myocardial infarction following transcatheter aortic valve replacement. J Am Coll Cardiol 2021;77:2187\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2021.03.014; PMID:\u00a033926655."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Khokhar AA, Giannini F, Zlahoda-Huzior A, et al. Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: insights from ex vivo simulations. Catheter Cardiovasc Interv 2022;100:662\u20136. https:\/\/doi.org\/10.1002\/ccd.30367; PMID:\u00a036116020.","DOI":"10.1002\/ccd.30367"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. JACC Cardiovasc Interv 2021;14:2097\u2013108. https:\/\/doi.org\/10.1016\/j.jcin.2021.06.033; PMID:\u00a034538602.","DOI":"10.1016\/j.jcin.2021.06.033"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv 2020;13:1030\u201342. https:\/\/doi.org\/10.1016\/j.jcin.2020.02.005; PMID:\u00a032192985.","DOI":"10.1016\/j.jcin.2020.02.005"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Redondo A, Baladr\u00f3n Zorita C, Tch\u00e9tch\u00e9 D, et al. Commissural versus coronary optimized alignment during transcatheter aortic valve replacement. JACC Cardiovasc Interv 2022;15:135\u201346. https:\/\/doi.org\/10.1016\/j.jcin.2021.10.005; PMID:\u00a035057983.","DOI":"10.1016\/j.jcin.2021.10.005"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Khokhar AA, Laricchia A, Ponticelli F, et al. Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: implications for coronary access. Catheter Cardiovasc Interv 2021;98:595\u2013604. https:\/\/doi.org\/10.1002\/ccd.29503; PMID:\u00a033586278.","DOI":"10.1002\/ccd.29503"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Ochiai T, Yamanaka F, Shishido K, et al. Impact of high implantation of transcatheter aortic valve on subsequent conduction disturbances and coronary access. JACC Cardiovasc Interv 2023;16:1192\u2013204. https:\/\/doi.org\/10.1016\/j.jcin.2023.03.021; PMID:\u00a037225290.","DOI":"10.1016\/j.jcin.2023.03.021"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Attizzani GF, Gabasha S, Ukaigwe A, et al. Coronary cannulation, commissure, and coronary alignment post-TAVR with Evolut FX system: CANNULATE TAVR study. JACC Cardiovasc Interv 2024;17:825\u20137. https:\/\/doi.org\/10.1016\/j.jcin.2023.10.033; PMID:\u00a037902149.","DOI":"10.1016\/j.jcin.2023.10.033"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Vanhaverbeke M, Nuyens P, B\u00e6kke PS, et al. Temporal trends in survival rates after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2022;15:1391\u20133. https:\/\/doi.org\/10.1016\/j.jcin.2022.04.038; PMID:\u00a035798488.","DOI":"10.1016\/j.jcin.2022.04.038"},{"key":"ref42","unstructured":"Bapat VN, Zaid S, Fukuhara S, et al. Surgical explantation after TAVR failure: mid-term outcomes from the EXPLANT-TAVR international registry. JACC Cardiovasc Interv 2021;14:1978\u201391. https:\/\/doi.org\/10.1016\/j.jcin.2021.07.015; PMID:\u00a034556271."},{"key":"ref43","unstructured":"Tang GHL, Zaid S, Kleiman NS, et al. Explant vs redo-TAVR after transcatheter valve failure: mid-term outcomes from the EXPLANTORREDO-TAVR international registry. JACC Cardiovasc Interv 2023;16:927\u201341. https:\/\/doi.org\/10.1016\/j.jcin.2023.01.376; PMID:\u00a037100556."},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Percy ED, Harloff MT, Hirji S, et al. Nationally representative repeat transcatheter aortic valve replacement outcomes: report from the Centers for Medicare and Medicaid Services. JACC Cardiovasc Interv 2021;14:1717\u201326. https:\/\/doi.org\/10.1016\/j.jcin.2021.06.011; PMID:\u00a034353602.","DOI":"10.1016\/j.jcin.2021.06.011"},{"key":"ref45","unstructured":"Landes U, Webb JG, De Backer O, et al. Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. J Am Coll Cardiol 2020;75:1882\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.051; PMID:\u00a032327098."},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Makkar RR, Kapadia S, Chakravarty T, et al. Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study. Lancet 2023;402:1529\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(23)01636-7; PMID:\u00a037660719.","DOI":"10.1016\/S0140-6736(23)01636-7"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Tarantini G, Nai Fovino L. Coronary access and TAVR-in-TAVR: don\u2019t put off until tomorrow what you can do today. JACC Cardiovasc Interv 2020;13:2539\u201341. https:\/\/doi.org\/10.1016\/j.jcin.2020.06.065; PMID:\u00a033153568.","DOI":"10.1016\/j.jcin.2020.06.065"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Akodad M, Sellers S, Gulsin GS, et al. Leaflet and neoskirt height in transcatheter heart valves: implications for repeat procedures and coronary access. JACC Cardiovasc Interv 2021;14:2298\u2013300. https:\/\/doi.org\/10.1016\/j.jcin.2021.07.034; PMID:\u00a034600879.","DOI":"10.1016\/j.jcin.2021.07.034"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Zaid S, Bapat VN, Sathananthan J, et al. Challenges and future directions in redo aortic valve reintervention after transcatheter aortic valve replacement failure. Circ Cardiovasc Interv 2023;16:e012966. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.012966; PMID:\u00a037988437.","DOI":"10.1161\/CIRCINTERVENTIONS.123.012966"},{"key":"ref50","unstructured":"Akodad M, Sellers S, Landes U, et al. Balloon-expandable valve for treatment of Evolut valve failure: implications on neoskirt height and leaflet overhang. JACC Cardiovasc Interv 2022;15:368\u201377. https:\/\/doi.org\/10.1016\/j.jcin.2021.12.021; PMID:\u00a035210043."},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Akodad M, Meier D, Sellers S, et al. A bench study of balloon-expandable valves for the treatment of self-expanding valve failure. EuroIntervention 2023;19:93\u2013102. https:\/\/doi.org\/10.4244\/EIJ-D-22-00769; PMID:\u00a036621917.","DOI":"10.4244\/EIJ-D-22-00769"},{"key":"ref52","unstructured":"Landes U, Richter I, Danenberg H, et al. Outcomes of redo transcatheter aortic valve replacement according to the initial and subsequent valve type. JACC Cardiovasc Interv 2022;15:1543\u201354. https:\/\/doi.org\/10.1016\/j.jcin.2022.05.016; PMID:\u00a035926921."},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Greenbaum AB, Kamioka N, Vavalle JP, et al. Balloon-assisted BASILICA to facilitate redo TAVR. JACC Cardiovasc Interv 2021;14:578\u201380. https:\/\/doi.org\/10.1016\/j.jcin.2020.10.056; PMID:\u00a033358650.","DOI":"10.1016\/j.jcin.2020.10.056"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Beneduce A, Khokhar AA, Curio J, et al. Impact of leaflet splitting on coronary access after redo-TAVI for degenerated supra-annular self-expanding platforms. EuroIntervention 2024;20:e770\u201380. https:\/\/doi.org\/10.4244\/EIJ-D-24-00107; PMID:\u00a038887883.","DOI":"10.4244\/EIJ-D-24-00107"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Zito A, Princi G, Lombardi M, et al. Long-term clinical impact of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. Europace 2022;24:1127\u201336. https:\/\/doi.org\/10.1093\/europace\/euac008; PMID:\u00a035138367.","DOI":"10.1093\/europace\/euac008"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Siontis GCM, J\u00fcni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 2014;64:129\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.033; PMID:\u00a025011716.","DOI":"10.1016\/j.jacc.2014.04.033"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Bisson A, Bodin A, Herbert J, et al. Pacemaker implantation after balloon- or self-expandable transcatheter aortic valve replacement in patients with aortic stenosis. J Am Heart Assoc 2020;9. https:\/\/doi.org\/10.1161\/JAHA.120.015896.","DOI":"10.1161\/JAHA.120.015896"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Hokken TW, Muhemin M, Okuno T, et al. Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: the INTERSECT registry. J Cardiovasc Comput Tomogr 2022;16:524\u201330. https:\/\/doi.org\/10.1016\/j.jcct.2022.07.003; PMID:\u00a035872136.","DOI":"10.1016\/j.jcct.2022.07.003"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"S\u00e1 MP, Van den Eynde J, Jacquemyn X, et al. Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: a meta-analysis of observational studies. Catheter Cardiovasc Interv 2023;101:1203\u201313. https:\/\/doi.org\/10.1002\/ccd.30666; PMID:\u00a037070459.","DOI":"10.1002\/ccd.30666"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Kawashima T, Sato F. Visualizing anatomical evidences on atrioventricular conduction system for TAVI. Int J Cardiol 2014;174:1\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.003; PMID:\u00a024750717.","DOI":"10.1016\/j.ijcard.2014.04.003"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Fujita B, K\u00fctting M, Seiffert M, et al. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 2016;17:1385\u201393. https:\/\/doi.org\/10.1093\/ehjci\/jev343; PMID:\u00a026758411.","DOI":"10.1093\/ehjci\/jev343"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Sharma E, McCauley B, Ghosalkar DS, et al. Aortic valve calcification as a predictor of post-transcatheter aortic valve replacement pacemaker dependence. Cardiol Res 2020;11:155\u201367. https:\/\/doi.org\/10.14740\/cr1011; PMID:\u00a032494325.","DOI":"10.14740\/cr1011"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Rudolph T, Droppa M, Baan J, et al. Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry. Open Heart 2023;10:e002191. https:\/\/doi.org\/10.1136\/openhrt-2022-002191; PMID:\u00a036750275.","DOI":"10.1136\/openhrt-2022-002191"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Jilaihawi H, Zhao Z, Du R, et al. Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement. JACC Cardiovasc Interv 2019;12:1796\u2013807. https:\/\/doi.org\/10.1016\/j.jcin.2019.05.056; PMID:\u00a031473236.","DOI":"10.1016\/j.jcin.2019.05.056"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Grubb KJ, Gada H, Fraser D, et al. Global results from the optimize PRO study: standardized TAVR technique and care pathway. J Soc CardioVasc Angiogr Interv 2025;4:103515. https:\/\/doi.org\/10.1016\/j.jscai.2025.103515; PMID:\u00a040454273.","DOI":"10.1016\/j.jscai.2025.103515"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"D\u2019Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J 2016;37:3515\u20133522a. https:\/\/doi.org\/10.1093\/eurheartj\/ehw229; PMID:\u00a027354049.","DOI":"10.1093\/eurheartj\/ehw229"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897\u2013902. https:\/\/doi.org\/10.1016\/s0002-9149(98)01064-9; PMID:\u00a010190406.","DOI":"10.1016\/S0002-9149(98)01064-9"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"G\u00f6ssl M, Stanberry L, Benson G, et al. Burden of undiagnosed valvular heart disease in the elderly in the community: heart of New Ulm valve study. JACC Cardiovasc Imaging 2023;16:1118\u201320. https:\/\/doi.org\/10.1016\/j.jcmg.2023.02.009; PMID:\u00a037052554.","DOI":"10.1016\/j.jcmg.2023.02.009"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Dujardin KS, Enriquez-Sarano M, Schaff HV, et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999;99:1851\u20137. https:\/\/doi.org\/10.1161\/01.cir.99.14.1851; PMID:\u00a010199882.","DOI":"10.1161\/01.CIR.99.14.1851"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 2013;61:1577\u201384. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.018; PMID:\u00a023433565.","DOI":"10.1016\/j.jacc.2013.01.018"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Testa L, Latib A, Rossi ML, et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention 2014;10:739\u201345. https:\/\/doi.org\/10.4244\/EIJV10I6A127; PMID:\u00a025330506.","DOI":"10.4244\/EIJV10I6A127"},{"key":"ref72","unstructured":"Poletti E, De Backer O, Scotti A, et al. Transcatheter aortic valve replacement for pure native aortic valve regurgitation: the Pantheon international project. JACC Cardiovasc Interv 2023;16:1974\u201385. https:\/\/doi.org\/10.1016\/j.jcin.2023.07.026; PMID:\u00a037648345."},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Adam M, Tamm AR, Wienemann H, et al. Transcatheter aortic valve replacement for isolated aortic regurgitation using a new self-expanding TAVR system. JACC Cardiovasc Interv 2023;16:1965\u201373. https:\/\/doi.org\/10.1016\/j.jcin.2023.07.038; PMID:\u00a037648344.","DOI":"10.1016\/j.jcin.2023.07.038"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Vahl TP, Thourani VH, Makkar RR, et al. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study. Lancet 2024;403:1451\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(23)02806-4; PMID:\u00a038552656.","DOI":"10.1016\/S0140-6736(23)02806-4"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Sanchez-Luna JP, Mart\u00edn P, Dager AE, et al. Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation. EuroIntervention 2023;19:580\u20138. https:\/\/doi.org\/10.4244\/EIJ-D-23-00344; PMID:\u00a037565470.","DOI":"10.4244\/EIJ-D-23-00344"}],"container-title":["Interventional Cardiology Reviews Research Resources"],"original-title":[],"link":[{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2024.40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:49:07Z","timestamp":1765198147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2024.40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":76,"URL":"https:\/\/doi.org\/10.15420\/icr.2024.40","relation":{},"ISSN":["1756-1477","1756-1485"],"issn-type":[{"value":"1756-1477","type":"print"},{"value":"1756-1485","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"article-number":"e35"}}